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Abstract
The two main agents of human malaria, Plasmodium vivax and Plasmodium falciparum, can induce severe anemia and
provoke strong, complex immune reactions. Which dynamical behaviors of host immune and erythropoietic responses
would foster control of infection, and which would lead to runaway parasitemia and/or severe anemia? To answer these
questions, we developed differential equation models of interacting parasite and red blood cell (RBC) populations
modulated by host immune and erythropoietic responses. The model immune responses incorporate both a rapidly
responding innate component and a slower-responding, long-term antibody component, with several parasite
developmental stages considered as targets for each type of immune response. We found that simulated infections with
the highest parasitemia tended to be those with ineffective innate immunity even if antibodies were present. We also
compared infections with dyserythropoiesis (reduced RBC production during infection) to those with compensatory
erythropoiesis (boosted RBC production) or a fixed basal RBC production rate. Dyserythropoiesis tended to reduce
parasitemia slightly but at a cost to the host of aggravating anemia. On the other hand, compensatory erythropoiesis
tended to reduce the severity of anemia but with enhanced parasitemia if the innate response was ineffective. For both
parasite species, sharp transitions between the schizont and the merozoite stages of development (i.e., with standard
deviation in intra-RBC development time #2.4 h) were associated with lower parasitemia and less severe anemia. Thus tight
synchronization in asexual parasite development might help control parasitemia. Finally, our simulations suggest that P.
vivax can induce severe anemia as readily as P. falciparum for the same type of immune response, though P. vivax attacks a
much smaller subset of RBCs. Since most P. vivax infections are nonlethal (if debilitating) clinically, this suggests that P.
falciparum adaptations for countering or evading immune responses are more effective than those of P. vivax.
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Introduction
The parasites that cause human malaria are inoculated by an
Anopheles mosquito and initially multiply in the liver. After about a
week, a primary wave of merozoite forms enters the bloodstream,
invades RBCs (within seconds), and continues the asexual cycle of
multiplication, developing into the schizont forms that burst and
release more merozoites. The pathology of malaria is due to this
asexual blood- stage cycle (reviewed in [1,2]). The sexual forms
transmissible to mosquitoes (gametocytes) appear over time, but in
much smaller numbers than the asexual forms. The two parasite
species that cause the vast majority of human cases, Plasmodium
vivax and Plasmodium falciparum, can induce severe anemia; with P.
vivax especially, the anemia can appear far out of proportion to the
percentage of RBCs infected [3].
Both the innate and adaptive arms of the human immune system
mount responses to infections with both species (reviewed in [4,5]).
High fevers are a classic feature of infections. During P. vivax
infections near-periodic episodes of fever (‘‘paroxysms’’) are associ-
ated with high levels of tumor necrosis factor a (TNF-a)a n do t h e r
cytokines associated with innate immunity [6–8]. Strong cytokine
responses also occur in P. falciparum infection, though the timing of
paroxysms tends to be irregular [9–11]. These fever paroxysms are
associated with the synchronized release of merozoites from bursting
schizonts. This synchronization has been the subject of considerable
experimental and theoretical work. It is possible that febrile
temperatures induce synchronization by differentially influencing
development rates of different parasite stages [12] and that immune
responses [13,14] as well as the host’s melatonin release cycle [15–17]
contribute to this phenomenon. But it is not yet clear whether
synchronization helps parasites, perhaps in the way a sudden
overwhelming abundance of prey may overwhelm a predator’s
capacity, or hinders them. Malaria parasites have certainly evolved
mechanisms of immune evasion; however, P. falciparum exhibits
antigenic variation [18], adheres to vascular endothelium in response
to fever [19], and produces prostaglandins which probably modulate
host TNF-a production [20]. This species also manages to keep the
membrane of infected RBCs deformable during its ring stage (RBCs
in the first 24 hours after infection), apparently reducing exposure of
ring-stage parasites to clearance by the spleen [21]. P. vivax can also
evade spleen clearance (reviewed in [22]) and suppress immune
responses directed against its liver stage [23].
Clinical investigations suggest that the malaria parasite and host
immune response interact with the host erythropoietic system in a
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tion of TNF-a by the host apparently induces anemia [25];
experimental evidence suggests that hemozoin produced by P.
falciparum suppresses RBC production [26]. Abnormalities ob-
served in P. falciparum-infected patients include suppression of
erythroid progenitor cells in bone marrow [27], sequestration of
parasites in the marrow [28], decreased iron absorption and
hemoglobin synthesis [29], and decreased RBC survival time [30].
Leucocyte infiltration of the marrow and erythroblast degradation
by macrophages have been observed in P. vivax infections [31].
Phagocytosis of uninfected RBCs has been observed in vitro and in
P. berghei-infected mice [32], and is suspected in human malaria
[33,34]. P. chabaudi-infected mice show enhanced erythropoiesis
that can compensate for RBC loss [34]; in humans, elevated levels
of erythropoietin are produced in response to P. falciparum infection
[35]. Overall, the evidence suggests that RBC destruction or
ineffective erythropoiesis may thwart erythropoietin-initiated
processes that might otherwise compensate for RBC loss, although
erythropoietin may have other protective effects [36].
Most fatal malaria infections are due to P. falciparum, which can
induce cerebral complications as well as severe anemia. P. vivax
infections are characterized by lower levels of parasitemia, and,
though often debilitating, are rarely fatal. P. falciparum attacks
RBCs of all ages, while P. vivax mainly attacks reticulocytes
(RBCs,1.5 days old, still showing remnants of nuclei) [37–39],
and possibly RBCs up to two weeks old [40]. In a previous report,
we argued that targeted depletion of the youngest RBCs makes P.
vivax infection potentially much more dangerous than is commonly
appreciated: unchecked growth of a P. vivax population would
eventually prevent the replacement of older, uninfected RBCs as
these senesce and are culled from the circulation [41]. Thus one
might expect a strong immune response to P. vivax, despite its
seemingly lower threat relative to P. falciparum. Furthermore, in
that model—which did not incorporate an immune response—
compensatory boosting of RBC production tended to increase
parasitemia, while dyserythropoietic response (reducing RBC
production below its basal rate) had the opposite effect.
Here we consider compartmentalized ordinary differential
equations (CODEs) representing P. vivax and P. falciparum
infections which incorporate a quick-acting innate response and
a longer-term acquired antibody response as well as a dynamic
erythropoietic system. Figure 1 shows the basic scheme; the details
are presented below in the Model section. The innate response
emulates aspects of the fever paroxysm response which is the
hallmark symptom of malaria. We analyze how these components
jointly affect parasite and RBC dynamics. We do not attempt to
model the full complexity of the immune response in malaria
infections: our aim is to assess potential trade-offs between host
and parasite for given characteristics of immune and erythropoi-
etic responses. However, we do consider several choices of targets
for both the innate and antibody responses in the model. We
assume that bursting schizonts activate the innate response, and
that the stage that triggers the antibody response is the same as the
stage it targets. (The intraerythrocyte stage terminology is
explained in the Model section.) We also consider different values
for the time constant of decay for the effective clearance rate of
parasites by the antibody response. This time constant is not
necessarily the biochemical decay constant of actual antibodies as
Author Summary
Of the four Plasmodium species that parasitize human
erythrocytes and induce malaria, Plasmodium falciparum
and Plasmodium vivax cause most of the public health
burden. P. falciparum infection is typically characterized as
‘‘malignant’’ (due to severe, sometimes lethal consequenc-
es, particularly in immune-naı ¨ve individuals), and P. vivax
malaria as (relatively) ‘‘benign.’’ Using the power of a
Beowulf cluster, we tested hypotheses about host control
of malaria by simulating ,8.4610
4 combinations of
parasite species, host immune response, and erythropoi-
etic response to infection. We tailored the models to
specific details of the life cycles of the two species, which
invade different subclasses of red blood cells. Our results
challenge some standard assumptions. For example, we
show that tight synchronization of the asexual reproduc-
tion of malaria parasites may actually benefit the host by
reducing parasitemia. We also demonstrate that properties
of host immunity or erythropoiesis that contribute to high
parasitemia and severe anemia in P. falciparum malaria
would do so in P. vivax infection as well, in line with recent
reports indicating that P. vivax can indeed cause ‘‘malig-
nant’’ illness in some patients. This suggests that P.
falciparum is more effective overall at immune evasion or
suppression than P. vivax.
Figure 1. Schematic of the model. (A) The RBC development chain, (B) the parasite development chain, (C) the quick-acting immune response
that emulates the innate response, (D) the longer-acting immune response that emulates an antibody response. TD=average duration of a stage of
development, and SD=standard deviation in the stage duration.
doi:10.1371/journal.pcbi.1000149.g001
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cells producing the antibodies. The models also incorporate a
nonzero standard deviation in the time parasites develop within
RBCs. We show that host erythopoietic response can affect
infection outcome even in the presence of sustained immunolog-
ical action. We show how infection outcome varies with the life
stages of parasite targeted by the model immune responses.
Furthermore, we show that a tight synchronization of merozoite
release does not necessarily help parasite populations evade host
immune responses. Most of our simulated infections assume that
the host has no pre-existing antibodies or memory B cells for the
parasite (and thus is ‘‘antibody-naı ¨ve’’), but for some examples we
examine the effects of pre-existing antibodies.
Results
Typical Simulations
A measurable quantity that constrains the model parameters is
the initial reproduction rate of a parasite, R0, defined as the
average number of descendants an individual parasite would have
at the beginning of bloodstream infection in the absence of any
host response to the parasite. As long as TDm (duration of the
merozoite stage)%the duration of the infected RBC stage, then by
probability arguments independent of model details [41],
R0~pfV0TDm 1zfV0TDm
 {1 ð1Þ
Here V0 is the initial density of the RBC population vulnerable
to the parasite species, f is the binding affinity of merozoites to
RBCs, and p is the average number of merozoites released per
bursting schizont. (For P. falciparum, V0=normal basal RBC
count=5610
6 ml
21; for P. vivax, V0=the basal reticulocyte
count=6.25610
4 ml
21.) Experimental evidence suggests that
TDm is just minutes; we take it as 0.1 h [42]. Data from the time
series of parasitemia in neurosyphilis patients infected with P. vivax
for malariatherapy [43] suggest that for P. vivax, R0,15. Similar
data for P. falciparum from neurosyphilis [44] and other patients
[45], as well as direct photographic evidence from studies of
bursting schizonts [46] suggest R0 and p are both $15 for that
species as well. Knowing R0, TDm, p, and V0 determines f. Because
we wanted to simulate infections with parasite growth rates seen
clinically, we used p=16 with R0=15 for both species. The
characteristic invasion time of an RBC by a merozoite in this
model, (jV0)
21, is 24 seconds. Equation 1 is consistent with our
CODEs in that if the immune response is absent, a steady state
with a nonzero parasite count exists only if R0.1 [41].
We simulated infections for up to one year after primary release
of merozoites (when they enter the blood from the liver), unless the
parasite population was cleared by the host first, or unless the RBC
count of the host declined to less than 60% of the normal basal
count of 5610
6 ml
21 (in which case it is assumed that the host
died). For each type of parasite and immune response, we
considered four model RBC source dynamics, described in detail
in the Model section: (1) RBC production increases to match the
RBC loss due to infection (compensatory response), (2) the RBC
production rate strongly declines in response to RBC loss, down to
65% of the basal rate (severe dyserythropoiesis), (3) a more
moderate dyserythropoiesis occurs, with RBC production rate
reduced down to 75% of the basal rate, and (4) RBC production
remains fixed at the basal rate. We cannot emulate the full
complexity of erythopoietic response in malaria, but these choices
represent plausible modalities in that response. Altogether, for
each of the two species of parasites we conducted about 3.8610
4
simulations with varying values of the erythropoietic and immune
parameters and targets for an antibody-naı ¨ve host. In addition, for
model P. vivax infections, we considered about 8610
3 simulations
in which a pre-existing level of antibody from a previous infection
was present; details are in the Model section.
Figure 2 shows results from typical simulations with an
antibody-naı ¨ve host. The parasitemia and immune factor time
series shown in panels A–D compare 2 model P. vivax infections
over the first 52 days after the primary release of parasites from the
liver into the bloodstream. For both simulations, the model
parameters for the parasites are the same, the rate of RBC
production is fixed, and the immune responses have the same
targets, but the binding affinities to those targets differ between the
2 models. In Figure 2A, note that the lower peak count of IBCs
(infected RBCs) occurs in the model with the larger, more
sustained innate-response-driven clearance rate, but it is in the
other model, with the larger antibody-driven clearance rate, that
the infection is completely cleared during this time span. (Note:
clearance rate=binding affinity to target6nominal level of the
component that attacks the target; see Model section.) Figure 2E
plots peak IBC count (IPK) against integrated IBC count (IINT, the
total number of IBCs produced during the infection) for all of the
P. vivax models with a fixed rate of RBC production. IPK versus
IINT plots for the other parasite species and erythropoietic
responses are similar (see Figure S1 for further examples). To
indicate severity of anemia, we use the RBC deficit, DRBC,
defined as 5610
6 ml
21 – (minimum RBC count during infection).
Figure 2F plots DRBC against IINT for all of the P. vivax
simulations for an antibody-naı ¨ve host with a fixed rate of RBC
production (black points) and moderate dyserythropoeisis (gray
points). Note that for the same IINT, DRBC tends to be (but is not
always) one-half to one order of magnitude higher (i.e., anemia is
much more severe) for the models with moderate dyserythropoei-
sis. Results for P. falciparum infections and for P. vivax infections
with pre-existing antibodies are similar (see Figure S1).
Effects of Variations in Model Parameters on Simulation
Outcomes
Peak and integrated parasitemia in individual simulations
depend on details of the interactions within the CODE model,
but the plots in Figure 3 indicate the trends in simulation outcomes
with changes in the immune response parameters in antibody-
naı ¨ve hosts. Note in panel A that an order of magnitude change in
the trigger level for the innate response leads to an order of
magnitude change in IPK and IINT on average. IPK and especially
IINT are sensitive to changes in the binding affinity of the antibody
response to its target (panels B and C), on average, but less so to
the decay time of the attacker component of the antibody response
(panel D). Note, too, in comparing panels B and C, that in order to
achieve the same degree of control of parasitemia, the binding
affinity of an antibody response targeting only merozoites must be
many orders of magnitude greater than one targeting an IBC
stage. Because the maximum nominal concentration of the
attacker component is fixed at 10 ml
21 for all antibody models
(see Model section), the corresponding clearance rates must also
differ by many orders of magnitudes for the same degree of
parasitemia control. This might be expected since free merozoites
either invade an RBC or else are cleared within a few minutes, and
thus are exposed to antibodies for a much shorter time than are
IBCs. Though the model antibody response against merozoites
works by removing them from the system, the model is also
plausible for antibodies which block merozoites from infecting
RBCs, since, as discussed above, merozoites are so quickly
removed from the blood.
Host Control of Malaria Infections
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In this section we consider simulated infections in which the
host has no innate immune response; in the next sections we show
that, as a class, model infections in which the host has an innate
response have qualitatively different behavior. This contrast might
be expected based on Figure 3A, which shows that the peak
parasitemia IPK for simulations without an innate response (but
with an antibody response) is orders of magnitude higher, on
average, than for simulations with an innate response even for the
smallest innate-parasite binding affinity and largest threshold of
innate activation considered. An examination of infection
outcomes without an innate response distinguishes outcomes to
which it is likely to be most and least crucial, and is not an
academic exercise: similar outcomes might occur if the parasite
were able to evade or suppress innate response such that it became
ineffective in eliminating parasites.
Figure 4 shows the values of several quantities averaged over all
simulated infections for each type of model antibody and
erythropoietic response that we considered. The host lacks an
innate response, and is antibody naı ¨ve. As noted above, results for
antibody responses which attack the merozoite stage cannot be
directly compared with those which attack IBC stages since
antibodies against merozoites must induce a much higher
clearance rate to be similarly effective. However, note that for
all types of antibody responses, the peak and integrated
parasitemia tend to be higher with compensatory erythropoiesis
than with dyserythropoiesis or with RBC production fixed at the
basal rate, strikingly so for P. vivax infections. Peak parasitemia IPK
in model P. falciparum infections is ,106IPK in P. vivax infections
(Figure 4A), as would be expected since a much smaller subset of
the RBC population can be infected by the latter species.
However, Figure 4B shows that IINT in P. vivax infections is of
the same order of magnitude as in P. falciparum infections. (The
same is also true for the DRBC; see Figure S2A.) Furthermore, for
a given combination of antibody and erythropoietic responses, the
fraction of simulated infections which ends in host death by
Figure 2. Some typical simulation results. Panels (A)–(D) show time series for several quantities for two model P. vivax infections with
SDI=2.4 h. TPR is the time since primary release. For both, the source rate of RBC production is fixed, the innate response targets the last half of IBC
development (late trophozoite-schizont stage), the host is antibody naı ¨ve, and the antibody response targets any part of the IBC stage. Black curve:
Ath=50ml
21, j=0.2 mlh
21 for the innate response, and Ath=0.5 ml
21, j=0.008 mlh
21,1 / lAtt=8,760 h for the antibody response. Gray curve:
Ath=50ml
21, j=1.0 mlh
21 for the innate response, and Ath=0.5 ml
21, j=0.0008 mlh
21,1 / lAtt=8,760 h for the antibody response. Where black and
gray overlap, black is shown. (A) IBC count (inset shows the time series on a semilog plot), (B) merozoite count, (C) clearance rate of IBCs by the innate
response, (D) clearance rate of IBCs by the antibody response, (E) the peak IBC count (IPK) plotted against the integrated IBC count (IINT) for all of the P.
vivax simulations with fixed RBC production rate, (F) the RBC deficit (DRBC) plotted against the integrated IBC count (IINT) for all of the P. vivax
simulations with fixed RBC production rate (black) and all of the P. vivax simulations with moderate dyserythropoiesis (gray).
doi:10.1371/journal.pcbi.1000149.g002
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(Figure 4C), except that the fraction of infections with host
antibodies to merozoites ending in death is lower for P. vivax than
for P. falciparum. (Incidentally, for infections with antibodies to
merozoites of either species, this fraction is lower with compen-
satory erythropoiesis than dyserthropoiesis.) But Figure 4A and 4B
show a major difference between the infection dynamics produced
by the two species: the ratio IPK/IINT in model P. falciparum
infections is just under 1, while in P. vivax infections it is closer to
1/20. This is the case because, if host death occurs, it occurs
within 2–5 weeks after primary merozoite release in P. falciparum
infection, but requires 8–15 weeks in P. vivax infection (see Figure
S3). Thus, much of the integrated parasitemia in P. falciparum
infection in this set of models is due to a final burst of parasite
production before host death. Another pattern is apparent in
Figure 4 among the antibody responses which target an IBC stage:
the longer the duration of vulnerability, the better the response is
at controlling parasitemia, reducing risk of host death, and
inducing parasite clearance in infections with either species. For
example, note in Figure 4D that 100% of infections with an
antibody response that attacked only the bursting schizont stage
(with no innate response present) ended in host death, but only
about 30% of those with antibodies that attacked infected RBCs of
all stages died. Furthermore, the latter, broad antibody response
resolved nearly 45% of infections by clearance of the parasite
within one year (Figure 4D). For model infections in which
parasites are cleared, clearance tends to occur within 2–6 weeks
after primary release; see Figure S3.
In the absence of an innate response, infection outcomes were
rather insensitive to differences in the standard deviation of the
development time of the parasite within the IBC (sIBC) (see
Figure 5 and Figure S2B). However, a shorter sIBC was associated
with a slightly higher peak and integrated parasitemia in model P.
falciparum infections (Figure 5A and 5B). Peak parasitemia in P.
vivax infection tended to be higher for a shorter sIBC as well, except
with antibodies that target the late trophozoite-schizont stage
(Figure 5A).
As mentioned above, we also did simulations that assumed a
level of pre-existing antibodies in the host. For this set of
simulations, we assumed that the species was P. vivax, and that
the antibodies could attack any IBC stage. (For more details see
Model section below.) We found that if there was no innate
response, the results were very similar to those shown in Figure 4
for this type of antibody response; see Figure S4.
Simulations with an Innate Response Present
Figure 6 is the same as Figure 4, in that it shows the values of
several quantities averaged over all simulated infections for each
type of model antibody and erythropoietic response, except that
the host also has an innate response. (As noted above, the model
innate responses can attack either the early trophozoite stage, the
late trophozoite/schizont stage, or the entire intraerythrocytic
Figure 3. Overall variations in parasitemia with changes in the model immune parameters. The host was antibody-naı ¨ve in all
simulations. (A) Plot of the peak (IPK) and integrated (IINT) parasitemia averaged over all simulations (results for P. vivax and P. falciparum combined)
with the corresponding values of target binding affinity j and antigen detection threshold Ath for the innate responses. The dotted lines show the
averages over simulations with no innate response. (B) Plot of IPK and IINT averaged over all simulations with the corresponding values of target
binding affinity j and threshold trigger sensitivity Ath for the antibody responses that do not target merozoites. (C) Plot of IPK and integrated IINT
averaged over all simulations with the corresponding values of target binding affinity j for the antibody responses that target merozoites. (D) Plot of
IPK and integrated IINT averaged over all simulations with the corresponding values of attacker decay time TAtt for all antibody responses. In (B), (C),
and (D), the dotted lines show the averages over all simulations with no antibody response. Note: In all panels, the vertical scale is logarithmic.
doi:10.1371/journal.pcbi.1000149.g003
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two figures are apparent. (Note the one order of magnitude
difference in the vertical scales between Figures 4 and 6 in panels
A and B.) First, parasitemia, on average, is much better controlled
by the host if an innate response is present: IPK (panel A) is
reduced a factor of 100–1000 and IINT (panel B) by a factor 5–10.
The presence of an innate response generally diminishes the effects
of erythropoietic response on IPK and IINT, notably of compen-
satory response on P. vivax. The striking exception is that here
severe diseryrthropoiesis with no antibody response, or an
antibody response only against bursting schizonts, decreases IINT
for both species. On the other hand, the fraction of hosts surviving
infections is sensitive to the nature of the erythropoietic response:
only with dyserythropoiesis did infections with model innate
responses end in host death (panel C). (This sensitivity to
erythropoietic response is mirrored in DRBC; see Figure S5A.)
Dyserythropoiesis with a broad antibody response slightly
increased the fraction of infections cleared (Figure 6D), but, even
with severe dyserythropoiesis, for all model antibody types, the
fraction of infections ending in host death was much lower if the
host mounted an innate as well as an antibody response. As with
Figure 4, for antibody responses that target an IBC stage, the
longer the duration of the vulnerable stage, the lower the peak and
integrated parasitemia, the lower the fraction of infections ending
Figure 4. Overall variation in outcome with different combi-
nations of Plasmodium species, erythropoietic and antibody
responses for model infections in antibody naı ¨ve hosts with no
innate response. (A) IPK and (B) IINT averaged over all simulations with
the given combination of species, erythropoietic response, and
antibody target. (C) Fraction of all simulations in which the host died,
and (D) fraction of simulations in which the host cleared the parasite for
the given combination of species, erythropoietic response, and
antibody target. (E) Color code for the data points and lines.
Abbreviations for antibody responses: None: no antibodies present;
IBC: any IBC stage; ET: early trophozoite; TS: late trophozoite-schizont
stage; BS: bursting schizont; Mer: merozoite. Abbreviations for
erythropoietic responses: SD: severe dyserythropoiesis; MD: moderate
dyserythropoiesis; FX: RBC production rate fixed at basal rate; CO:
compensatory erythropoiesis. Lines are just to guide the eye. If the data
points and connecting lines for two or more antibody responses
overlap in the plot, the lines are dashed to reveal all the responses
present. Note in Panel A that the vertical scale on the plots is different
between the two species.
doi:10.1371/journal.pcbi.1000149.g004
Figure 5. Overall variation in outcomes with different combi-
nations of Plasmodium species, antibody responses, and
standard deviations in the intraerythrocytic development time
(sIBC) for model infections in antibody naı ¨ve hosts with no
innate response. (A) IPK and (B) IINT averaged over all simulations with
the given combination of species, sIBC, and antibody target. (C) Fraction
of all simulations in which the host died for the given combination of
species, sIBC, and antibody target. (D) Color code for the data points
and lines. Abbreviations for antibody responses as in Figure 4. Lines are
just to guide the eye. If the data points and connecting lines for two or
more antibody responses overlap in the plot, the lines are dashed to
reveal all the responses present.
doi:10.1371/journal.pcbi.1000149.g005
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parasite is cleared.
Figure 7 again shows values of several quantities averaged over
all simulated infections (in antibody naı ¨ve hosts with innate
responses) for each type of innate response and erythropoietic
response. (The averaging process includes averaging over all
model antibody responses for the given innate and erythropoietic
response.) For all three innate responses studied, the risk of host
death is highly sensitive to the nature of the erythropoietic
response. (So is DRBC; see Figure S5B.) If the early trophozoite
IBC stage is targeted by the innate response, IPK tends to be lower
than for the other two types of innate targets (Figure 7A).
However, IINT is lower if the late trophozoite-schizont stage is
targeted (Figure 7B). The early trophozoite is a slightly better
target than the late trophozoite-schizont in terms of reducing the
Figure 6. Overall variation in outcome with different combi-
nations of Plasmodium species, erythropoietic and antibody
responses for model infections in antibody naı ¨ve hosts that
mount an innate response. (A) IPK and (B) IINT averaged over all
simulations with the given combination of species, erythropoietic
response, and antibody target. (C) Fraction of all simulations in which
the host died, and (D) fraction of simulations in which the host cleared
the parasite for the given combination of species, erythropoietic
response, and antibody target. (E) Color code for the data points and
lines. Abbreviations as in Figure 4. Lines are just to guide the eye. If the
data points and connecting lines for two or more antibody responses
overlap in the plot, the lines are dashed to reveal all the responses
present. (Note: the vertical scale for panel D is different from one in
Figure 4D.)
doi:10.1371/journal.pcbi.1000149.g006
Figure 7. Overall variation in outcome with different combi-
nations of Plasmodium species, erythropoietic and innate
responses for model infections in antibody naı ¨ve hosts that
mount an innate response. (A) IPK and (B) IINT averaged over all
simulations with the given combination of species, erythropoietic
response, and innate immunity target. (C) Fraction of all simulations in
which the host died, and (D) fraction of simulations in which the host
cleared the parasite for the given combination of species, erythropoietic
response, and innate target. (E) Color code for the data points and lines.
Abbreviations for innate responses: IBC: any IBC stage; ET: early
trophozoite; TS: late trophozoite-schizont stage. Abbreviations for
erythropoietic responses as in Figure 4. Lines are just to guide the
eye. If the data points and connecting lines for two or more antibody
responses overlap in the plot, the lines are dashed to reveal all the
responses present.
doi:10.1371/journal.pcbi.1000149.g007
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enhancing clearance (Figure 7D). The broad response, covering
both IBC stages, is best at enhancing clearance but, with severe
dyserythropoiesis, worst at reducing the risk of host death. Because
the late trophozoites and schizonts are believed to be the parasite
stages most vulnerable to fever [47], we will return to these points
in the Discussion.
Another striking aspect of both Figures 6 and 7 is that infections
with P. vivax and P. falciparum have very similar outcomes, on
average, when the host can mount an innate attack on the
parasite. We found that the differences between the species in the
values of IPK and IINT averaged over a given immune and
erythropoietic response were sometimes as small as 1%. One
major difference between the species is that, with a dyserythro-
poeitic response, the fraction of infections ending in host death is
higher for P. vivax infections than for P. falciparum infections
(Figures 6C and 7C). This result holds true, on average, for each
type of antibody response and innate response. Apparently, since
P. vivax attacks the youngest RBCs, even a low-level parasitemia
can deplete the number of RBCs that mature, which in turn can
more often or more quickly lead to catastrophic anemia if the rate
of RBC production is reduced. On the other hand, in P. falciparum
infections, low-level depletion of the general RBC pool by the
parasite may be less critical. (Even for infections with compensa-
tory erythropoiesis or a fixed rate of RBC production, in which the
outcome tends to be much less severe for the host, DRBC is higher
for hosts infected with P. vivax than with P. falciparum, for all types
of immune responses; see Figure S5). With a host innate response,
with either parasite species and each type of antibody and
erythropoietic response, host deaths that ended infections occurred
at least 20 weeks after primary merozoite release, on average,
much longer than if no innate response were present; see Figure
S6. With infections resolved by parasite clearance, for each
antibody and erythropoietic response the average time from
primary release to clearance was 1–6 weeks; see Figure S6).
Among the simulations of P. vivax infections in hosts with pre-
existing antibodies to IBCs of all stages, we found essentially the
same trends as in Figure 7: for all model erythropoietic responses,
the innate response which attacks the late trophozoites and
schizonts is more effective, on average, than the other two in
reducing IINT and DRBC, while dyserthyropoiesis greatly
aggravates DRBC and increases the frequency of host death, even
if it also slightly increases the frequency of parasite clearance (see
Figure S7).
Consistency of Development Time and Infection
Outcome with an Innate Response
As shown in Figure 5, if no host innate response is present,
parasitemia is either insensitive to sIBC or higher for smaller sIBC,
depending on the parasite species and antibody response. The
situation is strikingly different if an innate response is present.
Figure 8 shows the values of several quantities from simulations
with an innate response averaged over the type of antibody
response and sIBC, and Figure 9 shows the values of the same
quantities averaged over the type of innate response and sIBC. (In
both figures, results are for antibody naı ¨ve hosts.) Note in these two
figures that IPK and IINT decline with decreasing sIBC, on average,
for each type of antibody response, for each type of innate
response, and for both parasite species. (The same is true for the
RBC deficit DRBC; see Figure S8.) Apparently, the faster rate of
schizont bursting which occurs with smaller sIBC triggers the
innate response more quickly and keeps parasitemia lower, on
average. The fraction of infections ending in host death also
declines with decreasing sIBC, though not necessarily monoton-
ically (Figures 8C and 9C). (For simulations that end in host death,
the time from primary merozoite release to host death tends to
increase with smaller sIBC, on average, though this effect is not
monotonic; see Figure S9.) The antibody response that attacks all
IBC stages and the innate response that attacks late trophozoites
and schizonts have, on average, lower IINT and DRBC than the
other model antibody and innate responses, respectively, for all
values of sIBC (Figures 8B and 9B, and Figure S8). The fraction of
infections ending in parasite clearance has a somewhat compli-
cated dependence on sIBC. If the innate response can attack the
Figure 8. Overall variation in outcome with different combi-
nations of Plasmodium species, standard deviations in the
intraerythrocytic development time (sIBC), and antibody re-
sponses for model infections in antibody naı ¨ve hosts that
mount an innate response. (A) IPK and (B) IINT averaged over all
simulations with the given combination of species, sIBC, and antibody
target. (C) Fraction of all simulations in which the host died, and (D)
fraction of simulations in which the host cleared the parasite for the
given combination of species, sIBC, and antibody target. (E) Color code
for the data points and lines. Abbreviations for antibody responses as in
Figure 4. Lines are just to guide the eye. If the data points and
connecting lines for two or more antibody responses overlap in the
plot, the lines are dashed to reveal all the responses present.
doi:10.1371/journal.pcbi.1000149.g008
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but is insensitive to the value of sIBC for the other two model
innate responses (Figure 9D). Interestingly, for some types of
model antibody response, simulations with an innate response
never lead to parasite clearance unless sIBC,4.8 hours
(Figure 8D).
For the set of simulations done for P. vivax infections assuming a
level of pre-existing antibodies to the entire IBC stage, the
variations of IPK, IINT, DRBC, fraction of infections ending in host
death, and fraction of infections ending in clearance of parasite
with sIBC were similar to the trends observed in the antibody naı ¨ve
hosts (see Figure S10).
Discussion
Our results provide some insights into real malaria infections
and parasite biology, despite the vast simplifications involved in
modeling immune and erythropoietic responses. First, anemia did
not lead to death in any simulation unless there was either
dyserythropoiesis or an absence of innate response. Apparently, for
P. vivax or P. falciparum infection to produce catastrophic anemia in
the presence of a fast-activating innate response, one of the
following must happen: (a) dyserythropoiesis, (b) a weakening of
the innate response, coupled with an adaptive response which fails
to check parasite growth, or (c) sustained destruction and/or
sequestering of uninfected RBCs (‘‘bystander effect’’). We did not
consider a bystander effect directly, but note that dyserythropoiesis
could amplify the resulting anemia. We cannot say anything
directly about host death due to other causes, but we note that
infections with high parasitemia (IPK.10
4 ml
21 or IINT.10
6 ml
21)
were the ones with no or very weak innate response (as illustrated
in Figures 3 and 4). Although control of the magnitude of peak
parasitemia was dominated by the presence or absence of an
innate response, our results suggest that an antibody response
which targets a significant duration of the intraerythrocyte stage
will reduce anemia and integrated parasitemia and boost the
likelihood that a host will clear the infection. Even an antibody
response that targets only merozoites would reduce parasitemia if
the reciprocal of the clearance rate is greater than the
characteristic time for a merozoite to find and invade an RBC
(as suggested by Figure 3D).
It is hardly surprising to find that the antibody response with the
widest possible range of targets produces the lowest frequency of
hostdeathandthehighestfrequencyofparasiteclearance(Figures4,
6, and 8). Our results emphasize the different durations over which
stage-specific antigens are exposed to antibody attack—an antibody
response that targets merozoites or bursting schizonts is much less
effective, for instance—and the value of an array of antibody
responses to an array of stage-specific antigens. With an immune
responsethatincludesinnateaswellasantibodycomponents,rather
than antibody alone, the frequency of host death is lower (compare
Figures 6C and 4C), and, as with real malaria infections, more
infections persist for long periods at low parasitemia.
It is the gametocytes that allow parasite genomes to be
transported between hosts, as modified by meiotic recombination
in the mosquito, and the conditions that regulate gametocyte
production and infectivity remain unknown. However, if the
production or infectivity of gametocytes is proportional to either
peak or integrated parasitemia, it appears unlikely that inducing
dyserythropoiesis would provide a transmission advantage to
either P. vivax or P. falciparum. Our calculations suggest that a
dyserythropoietic response to infection, compared to compensa-
tory erythropoiesis or RBC production held at the basal rate,
would suppress IPK and IINT, most dramatically in hosts lacking an
innate response to P. vivax (Figure 4), but also for IINT for both
species, in hosts with both immune-response components engaged
(Figure 6). In the latter case, though dyserthropoiesis can slightly
increase the frequency of parasite clearance, it can substantially
increase the risk of severe anemia and host death. Our model does
not consider the possibility that induction of dyserythropoiesis
might be accompanied by reduced effectiveness of immune
responses, however.
It is possible that enhanced parasitemia enhances propagation
of the parasite’s genome, presumably by boosting gametocytemia,
Figure 9. Overall variation in outcome with different combi-
nations of Plasmodium species, standard deviations in the
intraerythrocytic development time (sIBC) and innate respons-
es for model infections in antibody naı ¨ve hosts that mount an
innate response. (A) IPK and (B) IINT averaged over all simulations with
the given combination of species, sIBC, and innate immunity target. (C)
Fraction of all simulations in which the host died, and (D) fraction of
simulations in which the host cleared the parasite for the given
combination of species, sIBC, and innate immunity target. (E) Color code
for the data points and lines. Abbreviations for innate responses as in
Figure 7. Lines are just to guide the eye. If the data points and
connecting lines for two or more antibody responses overlap in the
plot, the lines are dashed to reveal all the responses present.
doi:10.1371/journal.pcbi.1000149.g009
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triggers an immune response that limits transmission, and thus that
the regulation of parasitemia or gametocytemia could benefit the
parasite in an evolutionary sense. In vitro experiments have shown
that typical febrile temperatures kill intraerythrocytic parasites in
the last but not the first 24 hours of their development [47].
Interestingly, in our CODE models, IINT (and thus the total
number of merozoites produced) is lower on average when the
innate response attacks the late trophozoites and schizonts rather
than the early trophozoites, a result that is a consequence of the
model dynamics. If there are parasite adaptations that involve direct
or indirect regulation of parasitemia that enhance gametocyte
transmission, then the parasite may actually benefit by the
vulnerability of the second half of the IBC stage to fever.
When an innate response is present in the model, compensatory
erythropoietic response leads to nearly the same IPK and IINT,o n
average, as RBC production fixed at the basal rate. Our results
show slightly lower anemia with a compensatory response than
with a fixed RBC production rate, in the presence of innate
immunity (Figure S5), but differences between the two in any
outcome are remarkably few and small, which implies that, in the
presence of an innate immune response, a compensatory
erythropoietic response confers little or no advantage or
disadvantage to either host or parasite. This marks a contrast to
some of our results with an earlier model [41] in which, specifically
to examine constraints on immune responses, we included only
parasite and RBC dynamics. In that context, compensatory
response boosted parasitemia and accelerated the onset of
catastrophic anemia in a set of model P. vivax infections. Our
conclusion here might change if there were long-term evasion or
suppression of the innate response by the parasite—since, in the
absence of an innate response, compensatory response boosts
parasitemia (Figure 4)—or if removal of uninfected RBCs boosted
RBC production well above rates that would compensate for
infection-induced RBC loss [32]. Overall, our results on the role of
erythropoietic response point to larger questions of how trade-offs
of compensatory and dyserythropoietic responses might balance,
and how differences between individuals translate into differences
in populations; the evolutionary aspects involve dynamics on
multiple scales, to be incorporated in future work [48].
Our results showed lower IPK and IINT for smaller values of the
standard deviation in the IBC development time, sIBC, provided
an innate response was present (see Figures 8 and 9). This was true
for all innate and antibody targets and for both species, suggesting
that a very tight synchronization of merozoite release by bursting
schizonts would not benefit the parasite if parasitemia correlates
with transmission probability. Furthermore, tight synchronization
benefits the host overall, through enhanced clearing of infections,
and reduced RBC deficits and frequencies of death. It has been
suggested, however, that the release of prostaglandins or other
factors by bursting schizonts during synchronization may suppress
immunity [20], an effect we did not consider. Furthermore, we
assumed that the model immune responses were not overwhelmed
by large increases in parasitemia, which should be true if the
response is provided by fever directly, or by a large reservoir of
antibody-producing cells. However, a limited pool of cells that
target and kill parasites could perhaps be overwhelmed by a
synchronized burst. And we did find that if the innate response is
absent, parasite synchronization yields little benefit for the host.
Again, these results indicate trade-offs that merit further
investigation [14].
Finally, we address the relative abilities of P. vivax and P.
falciparum to cause catastrophic illness. In our previous report—on
a model which incorporated erythropoeitic but not immune
responses—we inferred that without an effective immune
response, P. vivax would be highly lethal, even for values of R0
just above 1, due to its depletion of reticulocytes and the
consequent eventual lack of replacements for senescent RBCs
[41]. Among the results of our new simulations, done with active
immune responses, two trends stood out when comparing the
outcome of simulated P. vivax infections with those caused by P.
falciparum: (1) for the same host immune and erythropoietic
responses, P. vivax produces DRBC values equal to or even greater
than those of P. falciparum, and (2) under similar conditions of
either dyserythropoiesis or an ineffective innate response, the
fraction of simulations ending in catastrophic anemia was just as
high or higher for P. vivax as for P. falciparum. In fact, as can be seen
in Figures 6C and 7C, no P. falciparum infections with both innate
response and moderate dyserythropoiesis ended in host death,
while a small fraction of P. vivax infections with those character-
istics did. Though real P. vivax infections are rarely fatal, they are
debilitating and trigger extremely strong immune responses (such
as the paroxysm response described above). Our new results
suggest that if these responses truly clear the parasite from the
blood, their strength is not inappropriately aggressive, and may be
a result of strong selective pressures from P. vivax malaria on
human innate and adaptive immune systems. Indeed, recent
reports of P. vivax malaria with severe organ complications [49],
splenic infarction [50], and retinal hemorrhage [51] suggest that P.
vivax can induce ‘‘malignant’’ illness in some individuals. There is
also an increased risk of low birthweight in infants born to mothers
with P. vivax malaria [52].
In both evolutionary and proximate terms, immune responses
shaped by P. vivax infections are likely to be partly but not
completely appropriate for P. falciparum infections, and vice versa
[53,54]. It may be that P. falciparum tends to cause more severe
illness often than P. vivax because it is more effective at evading,
suppressing or otherwise subverting the human immune responses
on a population average. These is also the possibility that
dyserythropoiesis is worse in P. falciparum infection. How these
and other factors play off in determining the relative transmission
success of the two species over multiple time scales is an intriguing
topic for future investigation.
Model
General Considerations
Our models are composed of compartmentalized ordinary
differential equations (CODEs) and are closely similar to models in
our previous work [41,54] but include immune responses. CODEs
are designed to simulate an ensemble of cells that, on average, take
a certain duration TD to pass through a development stage. The
standard deviation in development time is
s~TDN{1=2
c ð2Þ
where Nc is the number of compartments used to model the
development stage [55,56]. We stress that TD and s are the
tangible quantities.
Figure 1 is a schematic representation of the model. RBCs
emerge from the bone marrow, and, if uninfected, circulate for 120
days [57]. We assume that RBCs of all age cohorts are vulnerable to
P. falciparum, but that P. vivax attacks only reticulocytes. The rate of
RBC loss due to infection can feed back to the RBC source, to
increase (compensatory response) or decrease (dyserythropoietic
response) the RBC production rate. The immune components of
our model are based on simple ideas from immunology, and
resemble models of immune response in both viral infections [58–
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triggers an initially self-amplifying (and eventually self-limiting)
actuator phase, which in turns initiates either an attacker phase, which
directly removes parasites, or a growth phase, which models the
division of B or T cells, in which case the product of the growth
phase initiates the attacker phase. The two-stage actuator-attacker
response emulates a quick-acting but short-lived innate response,
while the three-stage actuator-growth-attacker response emulates a
slower-acting adaptive response, such as the production of
antibodies against a target. As real antibody responses have control
mechanisms that keep them from reaching destructive levels
(reviewed in [61]), in our three-stage model immune response the
attacker phase is also self-limiting.
We now introduce the equations of motion for the system,
starting with those for the parasite population. Then we consider
those for the RBC population and the immune factors.
Parasite Population Dynamics
Let TDI be the average duration of the infected RBC stage, with
standard deviation sIBC. Then NcI=TDI
2/sIBC. is the number of
compartments needed to described the IBC development. Let In
be number of infected RBCs per ml in compartment n. Then
dI1,=dt~fmV{ kIzSm Attmjm,1

I1
dIn=dt~kIIn{1{ kIzIn Sm Attmjm,n

In,1 vnvNcIz1
ð3Þ
Here kI=NcI/TDI, m is the merozoite density, f is the binding
affinity between the merozoites and vulnerable RBCs, and V is the
total density of vulnerable RBCs for a given species: for P. vivax,
V=uninfected reticulocyte count, and for P. falciparum, V=ET, the
total uninfected RBC count. The infected RBCs (IBCs) could
themselves be vulnerable to several immune system components:
Attm refers to the density of the attacker phases of component m,
and jm,n is the binding affinity between the attacker phase of
immune component m and the parasite in compartment n.W e
allow j to have dependence on n in order to emulate an age-
specific immune attack on IBCs. This is valid within the CODEs
formalism provided one realizes that if Nsub is the number of
compartments associated with a subinterval of the IBC stage, the
standard deviation in the time any one IBC spends in the
subinterval is ,TDINsub
1/2/NcI. We took TDI=48 h for both P.
vivax and P. falciparum [1]. For each immune and erythropoietic
response, we evaluated the model’s behavior for several values of
sIBC (given in Table 1). The discussion after Equation 1 gives the
details on how the value of f is set.
We use just one compartment for the merozoite stage, due to its
short survival time in the blood, TDm=sm=0.1 h [42]:
dm=dt~pkIINcI{mfV{1

TDm

{m Sm Attmjm,mzLt ðÞ ð 4Þ
Here, p is the number of merozoites released per bursting IBC
after development and asexual division are completed within an
IBC; the choices for p are discussed below. Parameter jm,m is the
binding affinity of immune response Attm to merozoites. L(t) is the
infusion of primary merozoites of the given species from the liver
into blood, which is believed to happen quickly and to involve
10
4–10
5 merozoites. For our simulations, the initial time (t=0)
corresponds to the release of the first parasite from the liver. For
simplicity, we took L(t)=0.002 (mlh )
21, for the first hour,
(corresponding to a release of 10
4 primary merozoites into a
blood volume of 5610
6 ml) and then zero afterwards. We redid
some simulations with 10
5 primary merozoites released, but this
had little effect on the outcome (results not shown).
In P. falciparum malaria, the IBCs sequester onto blood vessel
walls during the second phase (last 24 hours) of parasite intra-RBC
development. Sequestered parasites can readily release large
numbers of merozoites that attack neighboring RBCs, however
[46]. Thus, in our model, we can consider the IBC compartments
to include sequestered as well as freely-circulating IBCs.
RBC Population Dynamics
The RBC development chain is divided into three parts. We
first consider RBCs attacked by P. falciparum; the CODEs for
reticulocytes are
dR1=dt~ES t ðÞ {kRR1{fmR1
dRn=dt~kR Rn{1{Rn ðÞ {fmRn,1 vnvNcRz1
ð5Þ
For mature RBCs:
dM1=dt~kR RNcR{kMM1{fmM1
dMn=dt~kM Mn{1{Mn ðÞ {fmMn,1 vnvNcMz1
ð6Þ
For senescent RBCs:
dS1=dt~kMMNcM{kSS1{fmS1
dSn=dt~kS Sn{1{Sn ðÞ {fmSn,1 vnvNcSz1
ð7Þ
(We separate the senescent stage from the mature stage to allow for
possible modeling of P. malariae infections, in which mainly
senescent RBCs are attacked.) Here, kR=NcR/TDR, kM=NcM/
TDM, and kS=NcS/TDS, where the TDR, TDM, and TDS are the
durations of the respective RBC stages, and NcR, NcM, and NcS are
the respective numbers of compartments used for each stage (as set
by Equation 2 above). ES(t) is the rate of new RBC production at
time t. Based on physiologically reasonable values [57], we took
TDR=36 h with s=6h, TDM=2,796 h with s=168 h, and
TDS=48 h with s=12 h. For P. vivax infections, the model for
RBC development is exactly the same, except that the mature and
senescent stages are not attacked at all by merozoites. The total
uninfected RBC count, ET, is equal to the sum of all the R, M, and
S compartments. If ET drops below 3610
6 RBCs ml
21 (i.e.,
0.66the basal count of a typical healthy adult), then we assume
that the host dies of catastrophic anemia. Studies of RBC or
hemoglobin levels in patients with either P. falciparum [29,62] or P
vivax [3] infections suggest that RBC counts can collapse to
similarly low fractions of the basal count.
Erythropoietic Response
The dynamics for the marrow RBC source depend on the host
response to losses of uninfected RBCs. Let W=ES 02dET/
Table 1. Values of Parameters for Model Parasites.
Species or Strain p R0
Standard deviation sIBC
in IBC duration (h)
P vivax 16 15 1.2, 2.4, 4.8, or 9.6
P falciparum 16 15 1.2, 2.4, 4.8, or 9.6
doi:10.1371/journal.pcbi.1000149.t001
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maintains a healthy basal count of 5610
6 ml
21), and f, m, and V
are as above in Equations 3 and 4. The factor d is a simplistic way
to account for the dyserythropoietic effects during infection. We
model the dynamics of ES(t) with the following ODE:
dES=dt~lES W{ES t ðÞ ðÞ ,E S MNvWvESMX
~lES ESMX{ES t ðÞ ðÞ , WwESMX
~lES ESMN{ES t ðÞ ðÞ , WvESMN
ð8Þ
ESMX is the maximum RBC production rate, and 1/lES is a
response time to changes in the rate of RBC loss. For a healthy
compensatory response to RBC loss [57], ESMX/ES0=5 and 1/
lES=48h. ES MN is a minimum production rate; with dysery-
thropoiesis, the RBC rate production would be driven to ESMN.A s
mentioned above, we considered four model RBC source
dynamics, the parameters specified in Table 2.
Immune Response Dynamics
As noted above, we consider two main types of immune actions:
a fast-activating but short-acting innate response, and a slower-
activating but long-acting antibody-like response. We consider the
innate response first. Let Act be the actuator level, Att the attacker
level, and A an antigen (targeted parasite stage) that triggers the
response. Actuator production above its basal rate is triggered
when the density of a target parasite stage A exceeds a detection
threshold Ath:
dAct=dt~H SAct ðÞ {lActAct
dAtt=dt~H SAtt ðÞ {lAttAtt
ð9Þ
where H(x)=x if x.0, zero otherwise, and
SAct~ SAct,Bza ActHD A ðÞ ðÞ 1{Act=ActMx ðÞ
DA~A{Ath
SAtt~lActAct{SAtt,th
SAct,B is the basal actuator level of production, a the self-
amplification, and ActMx the maximum allowed actuator level.
Parameter SAtt,th is fixed by the other parameters so that
production of the attacker does not begin unless the actuator
production is above its basal level. Since schizont rupture is
believed to trigger the short-term innate reaction associated with
paroxysms in P. vivax infection [7], we took the actuator phase to
be sensitive to the count of IBCs in the last 4% of their
development cycle (‘‘bursting schizonts’’). Clinical studies have
shown rapid growth and quick decay of TNF-a levels in P. vivax
infections [6], on the order of 1–2 h. Fever spikes follow the TNF-
a peaks and also decay quickly in such patients, on the order of 2–
3 h. For the simulations reported here, we assumed 1/lAct=1h,
ActMx=2.5 ml
21, with SAct,B set so that the basal actuator level is
0.1, a=100, and 1/lAtt=2 h. Test simulations indicated that
model results were rather insensitive to values of these parameters
as long as lAct and lAtt were ,1h
21 (results not shown).
Simulation outcomes were sensitive to the antigen detection
threshold Ath (see Equation 9) and to j, the binding affinity to the
target of the response (as defined in Equations 3 and 4). In our
simulations, we considered three values of Ath (given in Table 3).
We also considered three targets for this response: (1) IBCs ,24 h
old, (early trophozoite), (2) IBCs between 24 and 48 h old (late
trophozoite and schizont), and (3) IBCs of any age. For each target
and sensitivity, we considered three values of binding affinity j
(given in Table 3). In a sense, the product j Att is the tangible
quantity, as this is the actual clearance rate of the subpopulation
targeted by this response.
For the antibody-like response (Ab response), the actuator
triggers an intermediate growth phase which imposes a delay on
the production of the attacker; thus, we use a multicompartment
model for it. Let Gn be the amount of intermediate phase in
compartment n, and let TDG be the duration of the growth phase
with standard deviation SDG:
dAct=dt~H SAct ðÞ {lActAct
dG1=dt~H lActAct{SGth ðÞ {kGG1
dGn=dt~kG Gn{1{Gn ðÞ ,1 vnvNcGz1
dAtt=dt~H SG,Att ðÞ {lAttAtt
ð10Þ
where
SAct~ SAct,BzaActHD A ðÞ ðÞ 1{Act=ActMx ðÞ 1{Att=AttMx ðÞ
DA~A{Ath
SG,Att~kGGNcG 1{Att=AttMx ðÞ
Parameters SAct,B, a, ActMx, lAct, Ath and lAtt have the same roles
as for the innate response, NcG is set by Equation 2 above,
kG=NcG/TDG, and AttMX is the maximum allowed level of the
attacker. SGth is set so that there is no production of the growth
phase unless the actuator is above its basal level. Note, too, that the
definition for SAct is slightly different from the one in equation 9, as
we allow for a shutdown of actuator production once the attacker
reaches its maximum level: all production of the attacker shuts
down once the attacker level reaches AttMx. Results with mouse
models suggest that the first specific activated B or T cells appear
4–7 days after inoculation with blood-stage parasites [63,64], so
we take TDG=96 hours, with s=9.6 hours. As for the innate
Table 2. Values of Parameters for Model Erythropoietic
Responses.
Name 1/lES (h) d ESMX/ES0 ESMN/ES0
Fixed Infinite – – –
Compensatory 48 0 5 0.65
Moderate dyserythropoietic 48 4.5 5 0.75
Severe dyserythropoietic 48 8.5 5 0.65
doi:10.1371/journal.pcbi.1000149.t002
Table 3. Parameter Values for Model Innate Responses.
Target Ath (ml
21) j (mlh
21)
All IBCs 0.5, 5, or 50 0.0008, 0.008, or 0.08
Early trophozoites 0.5, 5, or 50 0.0008, 0.008, or 0.08
Late trophozoites and schizonts 0.5, 5, or 50 0.0008, 0.008, or 0.08
No target – 0
doi:10.1371/journal.pcbi.1000149.t003
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21 and SAct,B set
so that the basal actuator level is 0.1. However, we took the self-
amplification factor a to be much smaller, 0.01. We set
AttMx=10ml
21. Again, the product jAtt is the tangible quantity,
not Att or j directly.
For the Ab response, we assume that the targeted subpopulations
of parasites also provide the trigger for the actuator. We considered
five possible targets: (1) early trophozoite, (2) late trophozoite and
schizont, (3) bursting schizonts (as defined above), (4) IBCs of any
age,and(5)merozoites.Testsimulationsindicatedthatifmerozoites
were the target of the model antibody response, then the binding
affinity j had to be many orders of magnitude larger and the trigger
threshold Ath much smaller than if the other subpopulations were
the target in order to achieve the same degree of control on
parasitemia. (This is in line with other studies [13,34]; see Results
sectionabove.) Thevaluesused forAthandj foreach of the targeted
parasite populations are given in Table 4. For all choices of target
population, Ath and j, we considered three values for the time decay
constant of the attacker phase, lAtt (also listed in Table 4). For
simplicity, we do not directly consider the effects of antigenic
variation in P. falciparuminfection.However, inorder to consider the
effects of an ineffective adaptive response, we did simulations with
an innate response but no antibody response, and, symmetrically,
simulations with an antibody response but no innate response.
For most of the simulations, we started with an antibody-naı ¨ve
host; i.e., the initial level of attacker component is zero. However, for
all model innate and erythropoietic responses to P. vivax infection, we
did addition simulations with pre-existing antibodies of the response
that targets IBCs of any age. The parameters j, Ath,a n dlAtt used for
this set of simulations have the same values as those listed for the ‘‘All
IBCs’’ model antibody response in Table 4. As mentioned above, the
initial antibody level is set at e
216AttMx,o r,3.679 ml
21.
Simulation Strategy
Tables 1–4 summarize the values used for all of the model
parameters which we varied from simulation to simulation. A
simulation was done for each possible choice of parameters in the
tables, thus results of 38,080 simulations for antibody-naı ¨ve hosts are
reported for each of the two Plasmodium species. In addition, we did a
further 8,064 simulations of P. vivax infection with pre-existing
antibodies. Model infections were simulated for up to one year after
the primary release of parasites from the liver into the bloodstream,
unless the host died from catastrophic anemia or the parasite was
cleared from the host before a full year elapsed. Although the ODE
system has hundreds to thousands of dependent compartmental
variables to solve, it is not stiff in the parameter regimes of interest,
and thus can be solved efficiently. Of course, we still only examined a
small part of the parameter space of the model,and in many ways our
model is a caricature of the real parasite-host system. Nonetheless, in
sweeping across these many combinations of parameter values we
identified several basic, broad trends with changes in the structures of
the immune and erythropoietic responses.
If at any point the merozoite count, the total infected RBC
count, or the total uninfected RBC count dropped to ,1 in a total
blood volume of 5610
6 ml, the values of all compartments that
contributed to that particular count were reset to zero. The
CODE system was solved using the fifth-order Runge-Kutta-
Fehlberg algorithm with adaptive stepsize control for time
integration [65,66], so that the difference between the fourth-
and fifth-order solutions for each component of the ODE systems
was less than one part in 10
6.
Supporting Information
Figure S1 Plots illustrating results for certain subsets of simulated
infections. (A) Peak parasitemia IPK versus integrated parasitemia
IINT for all model P. falciparum infections with fixed RBC rate of
production and antibody naı ¨ve host. (B) RBC deficit DRBC versus
integrated parasitemia IINT for all model P. falciparum infections with
antibody naı ¨ve hosts and with fixed RBC rate of production (black
points) and or with moderate dyserythropoiesis (gray points). (C)
Peak parasitemia IPK versus integrated parasitemia IINT for all
model P. vivax infections with fixed RBC rate of production with
pre-existing antibodies that attack all IBCs. (D) RBC deficit DRBC
versus integrated parasitemia IINT for all model P. vivax infections
withpre-existing antibodies that attack all IBCs and with fixed RBC
rate of production (black points) and or with moderate dysery-
thropoiesis (gray points).
Found at: doi:10.1371/journal.pcbi.1000149.s001 (0.88 MB TIF)
Figure S2 Overall variation in variation in anemia with different
combinations of Plasmodium species, erythropoietic, antibody and
intraerythrocytic development time (sIBC) for model infections in
antibody naı ¨ve hosts with no innate response. (A) DRBC averaged
over all simulations with the given combination of species,
erythropoietic response, and antibody target. (B) DRBC averaged
over all simulations with the given combination of species, sIBC,
and antibody target. (C) Color code for the lines in panels (A) and
(B). Abbreviations for antibody and erythropoietic responses as in
Figure 4 of text. If the data points and connecting lines for two or
more antibody responses overlap in the plot, the lines are dashed
to reveal all the responses present.
Found at: doi:10.1371/journal.pcbi.1000149.s002 (0.25 MB TIF)
Figure S3 Variation in time until resolution of infection with
different combinations of Plasmodium species, erythropoietic and
antibody responses for infections in antibody naı ¨ve hosts without
innate responses. (A) Time after primary release until death
averaged over all those infections which ended in death of host by
anemia, and (B) time from primary release until clearance of
parasite from host averaged over all those infections in which the
host cleared the parasite within one year for the given combination
of species, erythropoietic response, and antibody target. (C) Color
codeforthe datapointsand lines.AbbreviationsasinFigure4inthe
main text. Lines are just to guide the eye. If the data points and
connecting lines for two or more antibody responses overlap in the
plot, the lines are dashed to reveal all the responses present. Note:
there was no clearance of infections in model host that either (i) lack
an innate response and an antibody response or (ii) lack an innate
response but had an antibody response to bursting schizonts.
Found at: doi:10.1371/journal.pcbi.1000149.s003 (0.20 MB TIF)
Figure S4 Overall variation in outcome for different erythro-
poietic responses to P. vivax infections in hosts with pre-existing
Table 4. Values of Parameters for Model Antibody Responses.
Target Ath (ml
21) j (mlh
21)1 / lAtt (h)
All IBCs 0.5, 5 0.0008, 0.008, or 0.08 160, 720, or 8760
Early trophozoites 0.5, 5 0.0008, 0.008, or 0.08 160, 720, or 8760
Late trophozoites
and schizonts
0.5, 5 0.0008, 0.008, or 0.08 160, 720, or 8760
‘‘Bursting’’ schizonts 0.5, 5 0.0008, 0.008, or 0.08 160, 720, or 8760
Merozoites 0.01 10, 100, 1000 or 10000 160, 720, or 8760
No target – 0 –
doi:10.1371/journal.pcbi.1000149.t004
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IPK, (B) IINT and (C) DRBC averaged over all simulations with the
given response, (D) fraction of simulations with a given response in
which the host died, (E) fraction of simulations with a given
response in which the parasite was cleared. Abbreviations as in
Figure 4 in the main text. Lines are just to guide the eye.
Found at: doi:10.1371/journal.pcbi.1000149.s004 (0.20 MB TIF)
Figure S5 Overall variation in variation in anemia with different
combinations of Plasmodium species, erythropoietic, antibody and
innate responses for model infections in antibody naı ¨ve hosts with
an innate response. (A) DRBC averaged over all simulations with
the given combination of species, erythropoietic response, and
antibody target. (B) Color code for the lines in panel (A).
Abbreviations for antibody responses as in Figure 4 of text. (C)
DRBC averaged over all simulations with the given combination
of species, erythropoietic response, and innate target. (D) Color
code for the lines in panel (C). Abbreviations for innate responses
as in Figure 7 of text. If the data points and connecting lines for
two or more antibody responses overlap in the plot, the lines are
dashed to reveal all the responses present.
Found at: doi:10.1371/journal.pcbi.1000149.s005 (0.41 MB TIF)
Figure S6 Variation in time until resolution of infection with
different combinations of Plasmodium species, erythropoietic and
antibody responses for model infections in antibody naı ¨ve hosts
that mount an innate responses. (A) Time after primary release
until death averaged over all those infections which ended in death
of host by anemia, and (B) time from primary release until
clearance of parasite from host averaged over all those infections in
which the host cleared the parasite within one year for the given
combination of species, erythropoietic response, and antibody
target. (C) Color code for the data points and lines. Abbreviations
as in Figure 4 in the main text. Lines are just to guide the eye. If
the data points and connecting lines for two or more antibody
responses overlap in the plot, the lines are dashed to reveal all the
responses present. Note: no host with P. vivax infection died unless
there was dyserthropoiesis. No host with P. falciparum infection died
unless there was severe dyserthropoiesis.
Found at: doi:10.1371/journal.pcbi.1000149.s006 (0.23 MB TIF)
Figure S7 Overall variation in outcome for different combina-
tions of innate and erythropoietic responses to P. vivax infections in
hosts with pre-existing antibodies to IBCs of any stage and that
mount an innate immunity. (A) IPK, (B) IINT and (C) DRBC
averaged over all simulations with the given combination of
responses, (D) fraction of simulations with a given combination in
which the host died, (E) fraction of simulations with a given
combination in which the parasite was cleared. Abbreviations as in
Figure 7 in text. Lines are just to guide the eye.
Found at: doi:10.1371/journal.pcbi.1000149.s007 (0.27 MB TIF)
Figure S8 Overall variation in variation in anemia with different
combinations of Plasmodium species, standard deviations in the
intraerythrocytic development time (sIBC), antibody and innate
responses for model infections in antibody naı ¨v eh o s t sw i t ha ni n n a t e
response. (A) DRBC averaged over all simulations with the given
combination of species, sIBC, and antibody target. (B) Color code for
the lines in panel (A). Abbreviations for antibody responses as in
Figure 4 of text. (C) DRBC averaged over all simulations with the
given combination of species, sIBC, and innate target. (D) Color code
for the lines in panel (C). Abbreviations for innate responses as in
Figure 7 of text. If the data points and connecting lines for two or
more antibody responses overlap in the plot, the lines are dashed to
reveal all the responses present.
Found at: doi:10.1371/journal.pcbi.1000149.s008 (0.30 MB TIF)
Figure S9 Variation in time until resolution of infection with
different combinations of Plasmodium species, standard deviations in
the intraerythrocytic development time (sIBC), and antibody
responses for model infections in antibody naı ¨ve hosts that mount
an innate responses. (A) Time after primary release until death
averaged over all those infections which ended in death of host by
anemia and (B) time from primary release until clearance of parasite
from host averaged over all those infections in which the host
cleared the parasite within one year for the given combination of
species,sIBC, and antibodytarget.(C) Color code forthe datapoints
and lines. Abbreviations as in Figure 4 in the main text. Lines are
just to guide the eye. If the data points and connecting lines for two
or more antibody responses overlap in the plot, the lines are dashed
to reveal all the responses present. Note: no host with either (i)
antibodies to bursting schizonts, (ii) merozoites, or (iii) lacking
antibodies could clear the parasite unless sIBC,4.8 hours.
Found at: doi:10.1371/journal.pcbi.1000149.s009 (0.27 MB TIF)
Figure S10 Overall variation in outcome for different combi-
nations of standard deviations in the intraerythrocytic develop-
ment time (sIBC) and innate responses to P. vivax infections in hosts
with pre-existing antibodies to IBCs of all stages and that mount
an innate immunity. (A) IPK, (B) IINT and (C) DRBC averaged over
all simulations with the given combination of responses, (D)
fraction of simulations with a given combination in which the host
died, (E) fraction of simulations with a given combination in which
the parasite was cleared. Abbreviations as in Figure 7 in text. Lines
are just to guide the eye.
Found at: doi:10.1371/journal.pcbi.1000149.s010 (0.28 MB TIF)
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